全文获取类型
收费全文 | 54923篇 |
免费 | 3585篇 |
国内免费 | 185篇 |
专业分类
耳鼻咽喉 | 490篇 |
儿科学 | 1577篇 |
妇产科学 | 1314篇 |
基础医学 | 7395篇 |
口腔科学 | 956篇 |
临床医学 | 7790篇 |
内科学 | 10494篇 |
皮肤病学 | 792篇 |
神经病学 | 5457篇 |
特种医学 | 1278篇 |
外科学 | 5867篇 |
综合类 | 720篇 |
一般理论 | 75篇 |
预防医学 | 6228篇 |
眼科学 | 888篇 |
药学 | 3457篇 |
1篇 | |
中国医学 | 112篇 |
肿瘤学 | 3802篇 |
出版年
2023年 | 242篇 |
2022年 | 307篇 |
2021年 | 1085篇 |
2020年 | 633篇 |
2019年 | 1105篇 |
2018年 | 1237篇 |
2017年 | 881篇 |
2016年 | 932篇 |
2015年 | 1227篇 |
2014年 | 1664篇 |
2013年 | 2591篇 |
2012年 | 3804篇 |
2011年 | 3990篇 |
2010年 | 2197篇 |
2009年 | 1923篇 |
2008年 | 3610篇 |
2007年 | 3805篇 |
2006年 | 3844篇 |
2005年 | 3697篇 |
2004年 | 3493篇 |
2003年 | 3337篇 |
2002年 | 3177篇 |
2001年 | 439篇 |
2000年 | 355篇 |
1999年 | 548篇 |
1998年 | 645篇 |
1997年 | 612篇 |
1996年 | 499篇 |
1995年 | 449篇 |
1994年 | 439篇 |
1993年 | 421篇 |
1992年 | 310篇 |
1991年 | 262篇 |
1990年 | 262篇 |
1989年 | 267篇 |
1988年 | 270篇 |
1987年 | 228篇 |
1986年 | 229篇 |
1985年 | 231篇 |
1984年 | 302篇 |
1983年 | 317篇 |
1982年 | 330篇 |
1981年 | 304篇 |
1980年 | 300篇 |
1979年 | 166篇 |
1978年 | 155篇 |
1977年 | 155篇 |
1976年 | 118篇 |
1975年 | 104篇 |
1974年 | 133篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
102.
Mats Bergstrom Azita Monazzam Pasha Razifar Susan Ide Raymond Josephsson Bengt Langstrom 《Journal of nuclear medicine》2008,49(7):1204-1210
For a PET agent to be successful as a biomarker in early clinical trials of new anticancer agents, some conditions need to be fulfilled: the selected tracer should show a response that is related to the antitumoral effects, the quantitative value of this response should be interpretable to the antitumoral action, and the timing of the PET scan should be optimized to action of the drug. These conditions are not necessarily known at the start of a drug-development program and need to be explored. We proposed a translational imaging activity in which experiments in spheroids and later in xenografts are coupled to modeling of growth inhibition and to the related changes in the kinetics of PET tracers and other biomarkers. In addition, we demonstrated how this information can be used for planning clinical trials. METHODS: The first part of this concept is illustrated in a spheroid model with BT474 breast cancer cells treated with the heat shock protein 90 (Hsp90) inhibitor NVP-AUY922. The growth-inhibitory effect after a pulse treatment with the drug was measured with digital image analysis to determine effects on volume with high accuracy. The growth-inhibitory effect was described mathematically by a combined E(max) and time course model fitted to the data. The model was then used to simulate a once-per-week treatment; in these experiments the uptake of the PET tracers (18)F-FDG and 3'-deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) was determined at different doses and different time points. RESULTS: A drug exposure of 2 h followed by washout of the drug from the culture medium generated growth inhibition that was maximal at the earliest time point of 1 d and decreased exponentially with time during 10-12 d. The uptake of (18)F-FDG per viable tumor volume was minimally affected by the treatment, whereas the (18)F-FLT uptake decreased in correlation with the growth inhibition. CONCLUSION: The study suggests a prolonged action of the Hsp90 inhibitor that supports a once-per-week schedule. (18)F-FLT is a suitable tracer for the monitoring of effect, and the (18)F-FLT PET study might be performed within 3 d after dosing. 相似文献
103.
104.
Patricia H. Arford 《Journal of nursing scholarship》2004,36(3):265-271
PURPOSE: To provide a primer for novice nurse scientists about the increasingly regulated human research environment. ORGANIZING CONSTRUCTS: Federal regulations and international guidelines about protection of human research participants are discussed, with particular attention to institutional review boards for human research. CONCLUSION: Understanding the processes used by institutional review boards to foster ethical human research promotes collaborative interactions and supports compliant research work. 相似文献
105.
106.
Caroline Bolton-Smith Marion E T McMurdo Colin R Paterson Patricia A Mole Julia M Harvey Steven T Fenton Celia J Prynne Gita D Mishra Martin J Shearer 《Journal of bone and mineral research》2007,22(4):509-519
Dietary supplementation with vitamin K(1), with vitamin D(3) and calcium or their combination, was examined in healthy older women during a 2-year, double-blind, placebo-controlled trial. Combined vitamin K with vitamin D plus calcium was associated with a modest but significant increase in BMC at the ultradistal radius but not at other sites in the hip or radius. INTRODUCTION: The putative beneficial role of high dietary vitamin K(1) (phylloquinone) on BMD and the possibility of interactive benefits with vitamin D were studied in a 2-year double-blind, placebo-controlled trial in healthy Scottish women > or =60 years of age. MATERIALS AND METHODS: Healthy, nonosteoporotic women (n = 244) were randomized to receive either (1) placebo, (2) 200 microg/day vitamin K(1), (3) 10 microg (400 IU) vitamin D(3) plus 1000 mg calcium/day, or (4) combined vitamins K(1) and D(3) plus calcium. Baseline and 6-month measurements included DXA bone mineral scans of the hip and wrist, markers of bone turnover, and vitamin status. Supplementation effects were tested using multivariate general linear modeling, with full adjustment for baseline and potential confounding variables. RESULTS: Significant bone mineral loss was seen only at the mid-distal radius but with no significant difference between groups. However, women who took combined vitamin K and vitamin D plus calcium showed a significant and sustained increase in both BMD and BMC at the site of the ultradistal radius. Serum status indicators responded significantly to respective supplementation with vitamins K and D. Over 2 years, serum vitamin K(1) increased by 157% (p < 0.001), the percentage of undercarboxylated osteocalcin (%GluOC) decreased by 51% (p < 0.001), serum 25-hydroxyvitamin D [25(OH)D] increased by 17% (p < 0.001), and PTH decreased by 11% (p = 0.049). CONCLUSIONS: These results provide evidence of a modest synergy in healthy older women from nutritionally relevant intakes of vitamin K(1) together with supplements of calcium plus moderate vitamin D(3) to enhance BMC at the ultradistal radius, a site consisting of principally trabecular bone. The substantial increase in gamma-carboxylation of osteocalcin by vitamin K may have long-term benefits and is potentially achievable by increased dietary intakes of vitamin K rather than by supplementation. 相似文献
107.
108.
Fear of falling, defined as a lack of self-confidence that one may avoid falls while doing everyday activities, may have serious consequences for elderly people. This article examines the prevalence, risk factors, and consequences of fear of falling in the elderly population; methods for assessing those fears; and suggests evidence-based interventions. Incorporating successful strategies into programs to reduce falling can result in improved patient outcomes as well as decreased healthcare utilization and costs. 相似文献
109.
RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature 总被引:12,自引:0,他引:12
Kai Temming Raymond M. Schiffelers Grietje Molema Robbert J. Kok 《Drug Resistance Updates》2005,8(6):381-402
During the past decade, RGD-peptides have become a popular tool for the targeting of drugs and imaging agents to alphavbeta3-integrin expressing tumour vasculature. RGD-peptides have been introduced by recombinant means into therapeutic proteins and viruses. Chemical means have been applied to couple RGD-peptides and RGD-mimetics to liposomes, polymers, peptides, small molecule drugs and radiotracers. Some of these products show impressive results in preclinical animal models and a RGD targeted radiotracer has already successfully been tested in humans for the visualization of alphavbeta3-integrin, which demonstrates the feasibility of this approach. This review will summarize the structural requirements for RGD-peptides and RGD-mimetics as ligands for alphavbeta3. We will show how they have been introduced in the various types of constructs by chemical and recombinant techniques. The importance of multivalent RGD-constructs for high affinity binding and internalization will be highlighted. Furthermore the in vitro and in vivo efficacy of RGD-targeted therapeutics and diagnostics reported in recent years will be reviewed. 相似文献
110.